Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer.

被引：0
|
作者：
Castellani, M. R. [1 ]
Chiesa, C. [1 ]
Botta, F. [2 ]
Azzeroni, R. [2 ]
Negri, A. [2 ]
Mansi, D. [1 ]
Maccauro, M. [1 ]
Orunesu, E. [1 ]
Seregni, E. [1 ]
Bombardieri, E. [1 ]
机构：
[1] Fdn IRCCS, Ist Nazl Tumori, Nucl Med Div, Milan, Italy
[2] Postgrad Hlth Phys Sch, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S417 / S417
页数：1
相关论文
共 50 条
  • [1] Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer patients can change subsequent clinical strategy
    Chiesa, C.
    Seregni, E.
    Botta, F.
    Castellani, R.
    Bombardieri, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S179 - S179
  • [2] Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
    Pacilio, Massimiliano
    Conte, Miriam
    Frantellizzi, Viviana
    De Feo, Maria Silvia
    Pisani, Antonio Rosario
    Marongiu, Andrea
    Nuvoli, Susanna
    Rubini, Giuseppe
    Spanu, Angela
    De Vincentis, Giuseppe
    [J]. DIAGNOSTICS, 2022, 12 (07)
  • [3] Radioiodine therapy of metastatic lesions of differentiated thyroid cancer
    Luster, M.
    Haenscheid, H.
    Freudenberg, L. S.
    Verburg, F. A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (06) : 21 - 29
  • [4] Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?
    Sun, F.
    Gerrard, G. E.
    Roberts, J. K.
    Telford, T.
    Namini, S.
    Waller, M.
    Flux, G.
    Gill, V. M.
    [J]. CLINICAL ONCOLOGY, 2017, 29 (05) : 310 - 315
  • [5] Dosimetry for radioiodine therapy of differentiated thyroid cancer in patients with renal disease on haemodialysis
    Happel, C.
    Kranert, W. T.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Truong, P. N.
    Wright, D.
    Diener, J.
    Gruenwald, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S356 - S356
  • [6] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Salvatori, Massimo
    Luster, Markus
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (04) : 821 - 828
  • [7] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Massimo Salvatori
    Markus Luster
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 821 - 828
  • [8] Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    de Keizer, B
    Brans, B
    Hoekstra, A
    Zelissen, PMJ
    Koppeschaar, HPF
    Lips, CJM
    Rijk, PP
    Dierckx, RA
    Klerk, JMH
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (03) : 367 - 373
  • [9] Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    Bart de Keizer
    Boudewijn Brans
    Anne Hoekstra
    Pierre M. J. Zelissen
    Hans P. F. Koppeschaar
    Cees J. M. Lips
    Peter P. van Rijk
    Rudi A. Dierckx
    John M. H. de Klerk
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 367 - 373
  • [10] Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer Dosimetry, Clinical Care, and Future Challenges
    Kumar, Praveen
    Damle, Nishikant Avinash
    Bal, Chandrasekhar
    [J]. CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : 158 - 167
12345